A Phase 1, Double Blinded, Placebo Controlled, Dose Comparison Trial to Evaluate the Safety, Immunogenicity and Schedule of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2018
At a glance
- Drugs Chikungunya virus vaccine (Primary)
- Indications Chikungunya virus infections
- Focus Adverse reactions; Pharmacodynamics
- 07 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 19 Oct 2017 Status changed from not yet recruiting to recruiting.
- 01 Feb 2017 New trial record